• Berberine, RXRα/PPARγ, and SASP in Atherosclerosis

  2026-09-03

  The 2025 study by Zheng and colleagues identifies an RXRα/PPARγ/NEDD4 pathway through which berberine suppresses SASP-associated inflammation in macrophage-derived foam cells and atherosclerotic plaques. Its combination of mouse disease modeling, foam-cell experiments, Smart-seq profiling, and macrophage-specific RXRα knockdown provides a useful framework for testing nuclear-receptor control of vascular senescence.

• AAV Nanobody Swapping for Precision Tropism

  2026-09-03

  Hoffmann and colleagues identify multiple AAV-DJ capsid hotspots that support nanobody insertion and enable receptor-directed tropism switching, including selective targeting of fibroblast activation protein-positive cancer cells. Their comparison of VP1 and VP2 designs indicates that VP2 insertion can better preserve vector production and infectivity, while combining FAP recognition with heparin-binding ablation reduces off-target infection.

• Rifampin: Mechanism and Research Workflows

  2026-09-02

  Rifampin is a rifamycin antibiotic and DNA-dependent RNA polymerase inhibitor used to impose controlled transcriptional stress in bacterial systems. Its defined target, resistance liability, and formulation constraints make it useful for bacterial resistance mechanism research, transcriptional regulation studies, and synthetic biology transcription inhibition.

• Deferoxamine as a Metal-Death Research Tool

  2026-09-02

  Deferoxamine and DeferoxamineB can do more than reduce cellular iron: they provide a powerful perturbation framework for distinguishing ferroptosis, cuproptosis, apoptosis, and autophagy in cancer assays. This guide connects metal chelation, metabolic cell-death research, and practical assay design.

• Halazone for Reproducible Assay Workflows

  2026-09-01

  Learn how Halazone (SKU BA1377) can support controlled water-disinfection and mechanistic neurophysiology workflows without being mistaken for a validated cell-viability reagent. This scenario-based guide covers concentration selection, compatibility, interpretation, stability, and practical vendor evaluation.

• Vincristine Sulfate: Assay Workflows

  2026-09-01

  Turn vincristine sulfate’s microtubule-disrupting activity into reproducible cell, imaging, and translational oncology workflows. This guide combines dose-finding, mechanism-focused readouts, troubleshooting, and a careful cross-domain interpretation of inflammation research.

• Clozapine N-oxide: Reading Itch Circuits

  2026-08-31

  Clozapine N-oxide (CNO) is more than a DREADDs activator: it is a causal tool for separating neuronal activity modulation from behavioral interpretation. This article uses lateral habenula itch research to explain assay design, controls, formulation, and translational limits.

• Poly (I:C) Workflows for IFN and Cell Maturation

  2026-08-31

  Build reproducible TLR3-driven assays with Poly (I:C), from water-based preparation and dose finding to interferon profiling and dendritic-cell maturation. This guide also shows how structural-genomics principles can improve assay controls without overstating what the reference study proves.

• ETV5, EZH2, and HCC Progression: Study Insights

  2026-08-30

  The reference study integrates pan-cancer transcriptomic and clinical data with hepatocellular carcinoma experiments to identify ETV5 as a prognostic factor linked to epigenetic regulation. Its functional results connect ETV5 to EZH2 activity, tumor-cell proliferation, and reduced response to GSK126, providing a rationale for studying ETV5 as a potential modifier of epigenetic drug sensitivity.

• TBK1 and Microglial Pyroptosis in Diabetic Neuropathy

  2026-08-29

  Liao et al. identify TANK-binding kinase 1 (TBK1) as a mechanistic driver of painful diabetic neuropathy by linking its activation in spinal microglia to NF-κB signaling, NLRP3 inflammasome activity, and pyroptotic cell death. Genetic silencing and pharmacological inhibition of TBK1 reduced neuropathic pain-related phenotypes and peripheral nerve injury in diabetic mouse models, supporting TBK1 as a tractable neuroinflammatory target.

• Halazone: Designing Redox-Aware Dual Assays

  2026-08-28

  Halazone is an antimicrobial sulfonamide derivative whose value extends from rapid water disinfection to mechanistic sodium-current research. This guide explains how redox conditions, formulation stability, and assay design determine whether those two applications generate interpretable data.

• Sumatriptan as an Anti-Inflammatory Agent

  2026-08-28

  Ala and colleagues synthesized evidence that sumatriptan may regulate inflammation beyond its established role in migraine treatment, linking 5-HT1B/1D signaling with cytokines, nitric oxide, CGRP, and cell-survival pathways. The review is especially useful as a hypothesis-generating framework for interpreting preclinical anti-inflammatory findings, while its heterogeneous evidence base limits direct clinical translation.

• CFDA-SE for Proliferation and Surface-Biology Assays

  2026-08-27

  CFDA-SE converts division history into a measurable fluorescence pattern, supporting lymphocyte, fibroblast, NK-cell, and bacterial proliferation studies. When paired thoughtfully with CD38 surface-proximity mapping, it helps distinguish changes caused by cell division from changes in adhesion, migration, or membrane organization.

• How IPA Controls TAA1 in Auxin Biosynthesis

  2026-08-27

  The 2022 PNAS study identifies indole-3-pyruvic acid (IPyA) as a feedback regulator of the tryptophan aminotransferase TAA1, resolving how the two-step auxin pathway coordinates precursor production with IAA formation. Its enzymology, chemical genetics, and cross-species evidence provide a framework for interpreting IPA-dependent changes in plant hormone research and designing more informative auxin biosynthesis assays.

• Streptavidin-HyperFluor 647: Workflow Guide

  2026-08-26

  Streptavidin-HyperFluor 647 combines high-affinity biotin recognition with red-shifted fluorescence for sensitive imaging, flow cytometry, and biotinylated antibody detection. This guide explains how to deploy it reliably while distinguishing conventional biotin readouts from newer biotin-free proximity-labeling platforms.

8025 records 1/535 page Next 12345 下5页 Last page